Table: Chugai Pharm -2024 group results (IFRS)

Chugai Pharmaceutical

30/01/2025 08:00

Jan 30 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Dec 31, 2024    Dec 31, 2023   Dec 31, 2025      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales           1.17 trln       1.11 trln                              
                 (+5.3 pct)      (-11.8 pct)                             
  Operating        542.00          439.17                                
                 (+23.4 pct)     (-17.7 pct)                             
  Pretax
  Net              387.32          325.47                                
                 (+19.0 pct)     (-13.1 pct)                             
  EPS Basic      235.39 yen      197.83 yen                              
  EPS Diluted    235.36 yen      197.80 yen                              
  Ann Div         98.00 yen       80.00 yen     250.00 yen               
  -Q2 Div         41.00 yen       40.00 yen     125.00 yen               
  -Q4 Div         57.00 yen       40.00 yen     125.00 yen               
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T